| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |